International Conference Clinically Relevant Drug Transporters 2016

Learn the different transporter strategies for drug development from our panel of industry experts Grappling with ‘inconvenient truths’: Pertinent issues in the measurement of kinetics Learn about the ITC paper on clinically important transporter polymorphisms How to understand the “Extended clearance concept” and to stablish a PBPK model to interpret clinical outcomes Transporter biomarkers in the clinic and application in the predictions of transporter mediated DDIs New cell-based approaches for better predictions of drug transport and cellular drug exposure Transporters as targets case studies: INDY inhibitors, SGLT2 inhibitors and CFTR modulators